Results 91 to 100 of about 4,443,105 (228)

Ultralow‐Power Floating‐Gate InGaZnO Content‐Addressable Memory for Wearable Electrocardiogram Anomaly Detection

open access: yesAdvanced Intelligent Systems, EarlyView.
This study introduces a subthreshold in‐memory anomaly detection architecture for wearable ECG monitoring using floating‐gate IGZO content‐addressable memories on a flexible substrate. Area‐engineered coupling provides a high subthreshold slope, while subthreshold operation realizes intrinsic exponential distance evaluation and linear voltage sensing ...
Hyung‐Jun Noh   +4 more
wiley   +1 more source

HeaTrace: A Parametric Design‐to‐Fabrication Workflow for Thermally Programmable Soft Robots

open access: yesAdvanced Intelligent Systems, EarlyView.
A programmable thermal actuation workflow enables soft robots to be designed and fabricated with embedded heaters that drive multiple responses. By combining performance‐driven heater design with multimaterial fabrication, the system supports thermally triggered shape change, stiffness tuning, and thermochromic visual response, as demonstrated through ...
Naresh Kumar Thanigaivel   +9 more
wiley   +1 more source

Cross talk between NKT and regulatory T cells (Tregs) in prostatic tissue of patients with benign prostatic hyperplasia and prostate cancer

open access: yes, 2014
Regulatory T cells (Tregs) and NKT cells are two subpopulations of T lymphocytes that independently regulate innate and adaptive immunity, but there is some evidence for cross-talk between Tregs and NKT cells, which allow a new immunoregulatory networks.
Sotošek-Tokmadžić, Vlatka   +7 more
core   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia   +16 more
wiley   +1 more source

Working with NKT cells - Pitfalls and practicalities

open access: yes, 2005
Our understanding of NKT cells has been rapidly advancing over recent years, with many research groups studying how these cells behave and how they can be manipulated to prevent disease. Although good progress has been made, a difficulty is the lack of a
Berzins, Stuart P.   +2 more
core   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher   +7 more
wiley   +1 more source

NKT cells in cardiovascular diseases [PDF]

open access: yes, 2017
Despite life-style advice and the prescription of cholesterol-lowering and anti-thrombotic drugs, cardiovascular diseases are still the leading cause of death worldwide.
Gijs H.M. van Puijvelde   +3 more
core   +1 more source

Extended routine lymphocyte immunophenotyping refines individual immune organization across a heterogeneous patient cohort

open access: yesCytometry Part B: Clinical Cytometry, EarlyView.
Abstract Routine TBNK immunophenotyping detects the major lymphocyte compartments but may underestimate the biologically relevant variation contributed by less frequent but well‐defined minor lymphocyte subsets. This study evaluated whether extending routine TBNK immunophenotyping with minor lymphocyte subsets provides complementary, analytically ...
Carlos Agustin Villegas Valverde   +5 more
wiley   +1 more source

Migration and homeostasis of NKT cells

open access: yes, 2010
TypescriptThesis (PhD) -- University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, 2010Includes bibliographical references (pages 187-220) and appendices (pages 221-233).NKT cells are a CD ld-restricted T cell lineage with the ability
Pitt, Lauren Alicia.
core   +1 more source

Neurofibromin 1 Impairs Natural Killer T-Cell-Dependent Antitumor Immunity against a T-Cell Lymphoma

open access: yesFrontiers in Immunology, 2018
Neurofibromin 1 (NF1) is a tumor suppressor gene encoding a Ras GTPase that negatively regulates Ras signaling pathways. Mutations in NF1 are linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome.
Jianyun Liu   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy